6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00643890 (ClinicalTrials.gov) | August 2008 | 24/3/2008 | Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease | Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects With Advanced Parkinson's Disease | Parkinson's Disease | Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus | Neurologix, Inc. | NULL | Terminated | 30 Years | 75 Years | Both | 44 | Phase 2 | United States |